Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

3.79USD
6:37pm GMT
Change (% chg)

$0.04 (+1.07%)
Prev Close
$3.75
Open
$3.85
Day's High
$3.85
Day's Low
$3.56
Volume
18,128
Avg. Vol
29,666
52-wk High
$13.87
52-wk Low
$3.22

Chart for

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $348.98
Shares Outstanding(Mil.): 20.93
Dividend: --
Yield (%): --

Financials

  CRVS.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.58 -- --
ROI: -40.42 8.99 14.48
ROE: -40.82 10.14 15.99

Earnings vs. Estimates